ArticleJBRA assisted reproduction2026
The anti-apoptotic and antioxidant effects of Naringenin in varicocele-induced testicular damage.
Article in JBRA assisted reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveVaricocele is a prevalent condition among the male population, representing a significant cause of male infertility. Naringenin, a flavonoid, has demonstrated significant antioxidant and anti-apoptotic properties.
methodsIn this study, 24 male Wistar rats were divided into four groups: control group, sham group, a varicocele-induced rat (VCL) group, and a varicocele-with-Naringenin (20 mg/kg) treatment group (N20+C). Following a 21-day period, the rats were euthanized, and the quality of the tissue, the level of oxidative stress, the expression levels of HSP70, and the expression levels of the genes VEGF, BCL-2, caspase-3, and IL-6 in the testes were evaluated.
resultsBased on H&E images, varicocele induced tissue damage was improved by Naringenin. The expression of HSP70 in the VCl group increased in comparison to the Sham group, and in the N20+C group (p<0.001) it was lower than in the VCL group (p<0.05). MDA in the VCL group increased, SOD and TAC decreased when compared to the Control group (p<0.01), and there was no significant difference between the N20+C and the Control group. In the VCL group the expression of VEGF (p<0.05), caspase-3 (p<0.001) and IL-6 (p<0.001) genes increased in the VCL Group, and BCL-2 (p<0.05) decreased in comparison to the Control group. The expression of VEGF (p<0.05) and BCL-2 (p<0.05) increased and caspase-3 (p<0.001) and IL-6 (p<0.001) genes decreased in the N20+C group when compared to the VCL group.
conclusionsNaringenin has been demonstrated to reduce oxidative stress and apoptosis through the intrinsic pathway in rats with varicocele. This finding suggests that naringenin may be a promising candidate for mitigating the adverse effects associated with varicocele.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.